Ellington Management Group’s Emergent Biosolutions EBS Stock Holding History

Ellington Management Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,600	Closed	-$224K	–	681
2017 Q2	$224K	Buy	+6,600	New	+$204K	0.03%	498
2016 Q3	–	Sell	-7,700	Closed	-$217K	–	647
2016 Q2	$217K	Buy	7,700 +1,300	+20%	+$51K	0.3%	123
2016 Q1	$233K	Buy	+6,400	New	+$226K	0.1%	316
2015 Q1	–	Sell	-10,200	Closed	-$278K	–	710
2014 Q4	$278K	Buy	+10,200	New	+$243K	0.09%	354

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Ellington Management Group's EBS Position: Q3 2017 in Review

Ellington Management Group sold out of Emergent Biosolutions (EBS) in Q3 2017, closing a stake of 6,600 shares — an estimated $224K sold.

Ellington Management Group first reported a position in EBS in Q4 2014 and held it in 4 quarters. The position peaked at $278K in Q4 2014. 198 funds tracked by Wall St. Rank hold EBS as of Q3 2017.

Ellington Management Group reported no remaining Emergent Biosolutions position as of Q3 2017 after selling out during the quarter.
Ellington Management Group sold 6,600 Emergent Biosolutions shares in Q3 2017, an estimated $224K.
Ellington Management Group first reported a position in Emergent Biosolutions in Q4 2014 and held it in 4 quarters.
Ellington Management Group's Emergent Biosolutions position peaked at $278K in Q4 2014.
198 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2017.

Based on Ellington Management Group's 13F filing for Q3 2017, filed 14 Nov 2017.